• Patent Title: Processes for the preparation of isotopologues of 3-(4-((4- morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof
  • Application No.: US14762336
    Application Date: 2014-01-21
  • Publication No.: US09695145B2
    Publication Date: 2017-07-04
  • Inventor: John Fitzgerald Traverse
  • Applicant: CELGENE CORPORATION
  • Applicant Address: US NJ Summit
  • Assignee: Celgene Corporation
  • Current Assignee: Celgene Corporation
  • Current Assignee Address: US NJ Summit
  • Agency: Jones Day
  • International Application: PCT/US2014/012287 WO 20140121
  • International Announcement: WO2014/116573 WO 20140731
  • Main IPC: C07D401/04
  • IPC: C07D401/04 C07D209/46
Processes for the preparation of isotopologues of 3-(4-((4- morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof
Abstract:
Provided are processes for the preparation of isotopologues of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoin-dolin-2-yl)piperidine-2,6-dione, or a pharmaceutically acceptable salt thereof.
Information query
Patent Agency Ranking
0/0